- Home
- KYMR vs RXO Comparison
KYMR vs RXO Comparison
Compare KYMR & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- RXO
- Stock Information
- Founded
- KYMR 2015
- RXO 2022
- Country
- KYMR United States
- RXO United States
- Employees
- KYMR N/A
- RXO N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- RXO
- Sector
- KYMR Health Care
- RXO
- Exchange
- KYMR Nasdaq
- RXO Nasdaq
- Market Cap
- KYMR 3.1B
- RXO 2.9B
- IPO Year
- KYMR 2020
- RXO N/A
- Fundamental
- Price
- KYMR $42.63
- RXO $14.97
- Analyst Decision
- KYMR Strong Buy
- RXO Hold
- Analyst Count
- KYMR 16
- RXO 15
- Target Price
- KYMR $58.94
- RXO $17.92
- AVG Volume (30 Days)
- KYMR 622.1K
- RXO 1.8M
- Earning Date
- KYMR 08-11-2025
- RXO 08-07-2025
- Dividend Yield
- KYMR N/A
- RXO N/A
- EPS Growth
- KYMR N/A
- RXO N/A
- EPS
- KYMR N/A
- RXO N/A
- Revenue
- KYMR $44,711,000.00
- RXO $5,559,000,000.00
- Revenue This Year
- KYMR $58.26
- RXO $34.70
- Revenue Next Year
- KYMR N/A
- RXO $7.16
- P/E Ratio
- KYMR N/A
- RXO N/A
- Revenue Growth
- KYMR N/A
- RXO 46.41
- 52 Week Low
- KYMR $19.45
- RXO $12.19
- 52 Week High
- KYMR $53.27
- RXO $31.98
- Technical
- Relative Strength Index (RSI)
- KYMR 49.94
- RXO 43.44
- Support Level
- KYMR $36.65
- RXO $13.85
- Resistance Level
- KYMR $44.94
- RXO $15.57
- Average True Range (ATR)
- KYMR 1.64
- RXO 0.80
- MACD
- KYMR -0.18
- RXO -0.06
- Stochastic Oscillator
- KYMR 72.14
- RXO 33.33
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.